Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely hyoscyamine sulfate 375 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscyamine sulfate 0.031mg/1 mL |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscyamine sulfate 0.5mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hyoscyamine sulfate 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscyamine sulfate 375 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscyamine sulfate 0.125mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscyamine sulfate 0.125mg/mL (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing atropine sulfate and hyoscyamine sulfate and scopolamine hydrobromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hyoscyamine sulfate dihydrate (substance) |
Is a |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely hyoscyamine sulfate 375 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hyoscyamine sulfate 375 microgram/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hyoscyamine sulfate 125 microgram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hyoscyamine sulfate 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hyoscyamine sulfate 375 microgram oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hyoscyamine sulfate 375 microgram oral tablet |
Has basis of strength substance (attribute) |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hyoscyamine sulfate dihydrate (substance) |
Is modification of (attribute) |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hyoscyamine sulfate 375 microgram/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hyoscyamine sulfate 125 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hyoscyamine sulfate 375 microgram oral tablet |
Has precise active ingredient |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
False |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Hyoscyamine sulfate 0.125mg/mL (product) |
Has precise active ingredient |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hyoscyamine sulfate 0.125mg/mL (product) |
Has basis of strength substance (attribute) |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hyoscyamine sulfate 25 microgram/mL oral solution |
Has basis of strength substance (attribute) |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hyoscyamine sulfate 25 microgram/mL oral solution |
Has precise active ingredient |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely atropine sulfate 19.4 microgram and hyoscyamine sulfate 103.7 microgram and scopolamine hydrobromide 6.5 microgram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hyoscyamine sulfate anhydrous |
Is modification of (attribute) |
True |
Hyoscyamine sulfate (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|